GET YOUR COVID-19 RESULTS ON SAME DAY OR IN 24 HRS
No Out-Of Pocket Costs Thru HSA, FSA, or Insurance claim. Receipts provided for reimbursement. Self-Pay accepted also.
Lab PCR is the gold standard of COVID-19 testing for the highest accuracy.
COVID-19 testing made easy. No lines, no Waits, Just Fast Results! Whether you need COVID-19 testing results for travel, for businesses, or for peace of mind, the Expert Team at
KONE MOLECULAR LABS™ delivers your results on time.
Results from
1 to 2 Days
We deliver your results via text, email, or a patient portal.
Highest Accuracy
At KONE MOLECULAR LABS™, we value the importance of accuracy. Our choice of high performance testing equipment are designated to do just that.
Travel Certificate
Come test with us! Travel Certificate provided on the day of results!
Drive-Thru Testing
You have options!
ON-DEMAND COVID TESTING
Use one of our drive-thru locations, we can come to you, or we can send you a collection kit of your choice!
Get Tested Today!
Nasal Swab; We'll come to you, or you may visit us at one of our collection/testing sites.
Your sample is processed immediately using the Abbott ID Ag Card to detect COVID-19.
Results within 15 minutes. (Results timeline subject to surge & positivity rates)
This is for the TEST ONLY; No report or Lab Certificate provided.
$18
Test Kit Options
(HSA and FSA; or Self-Pay)
• Saliva Based Kit
• Nasal Swab Kit
Shipping Instructions
√ Step 1: Select your kit of choice to receive it within 24hours in the comfort of your home or office via UPS or FedEx
√ Step 2: Collect your sample and ship it back using the provided prepaid package
√ Step 3: RT-PCR Analysis of your sample (s) in our High-Complexity CLIA / CAP Certified Lab, FDA & EUA-Approved
√ Step 4: Receive your results online on same day or 24hrs via email, or patient portal (Your choice)
√ Step 5: Official Lab Report (s) provided
Self-Collected Saliva Based Sample Kit
Self-Collected Saliva Based Sample Kit is for RT-PCR Lab Test. Kit includes
Self-Collected Nasal Swab Test Kit
Our Test
Our methodology we utilize to test for the SARS-CoV-2 virus is a state-of-the-Art RT-PCR testing process developed by experts in the field. The methodology is extremely sensitive, and it is listed as one of the most sensitive and specific SARS-CoV-2 test method out of more than 100 tests validated by the FDA (FDA: SARS-CoV-2 Reference Panel Comparative Data, 12/2020)
The assay is a multiplex rRT-PCR assay consisting of one reaction with primers and probes for the viral targets (Orf1ab, N and E genes) and internal control in one tube thus with increased assay throughput and ease of use and other advantages as a multiplex assay.
The Orf1ab, N, and E genes of the SARS-CoV-2 genome are targeted in the rRT-PCR assay. Primers and TaqMan probes designed for conserved regions of the SARS- CoV-2 virus genome allow specific amplification and detection of the viral RNA from all strains of SARS-CoV-2 from respiratory specimens. The Human RNase P gene is used as Internal control to monitor viral RNA extraction efficiency and assess amplifiable RNA in the samples to be tested.
High Throughput & Ease of Use
-
Detected Genes
-
Orf1ab, N and E genes
-
-
High Throughput
-
93 samples (96-well plate) or 381 samples (384-well plate) per run
-
-
Ease of Use
-
One sample in one qPCR reaction well (1 assay mix/per sample)
-
-
What is COVID-19?COVID-19 is an illness caused by a new respiratory virus (SARS-CoV-2). In December 2019, the virus began circulating in humans.Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases. The COVID-19 epidemic was declared by the WHO as a public health emergency of international concern on January 30, 2020. The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, announced on 11 March 2020 that the new coronavirus disease 2019 (COVID-19) can be characterized as a pandemic. Describing the situation as a pandemic means that the epidemic has spread to several countries, continents or throughout the world, and that it affects large numbers of people.
-
What are the symptoms of COVID-19?Symptoms may appear two to 14 days after exposure to the virus. Common symptoms are: − Fever or chills − Cough − Shortness of breath or difficulty breathing − Fatigue − Muscle or body aches − New loss of taste or smell − Sore throat − Congestion or runny nose − Nausea or vomiting − Diarrhea If you develop emergency warning signs for COVID-19, get medical attention immediately. Emergency warning signs include: − Trouble breathing − Persistent pain or pressure in the chest − New confusion or inability to arouse − Bluish lips or face This list is not all inclusive. Please consult your doctor for any other symptoms that are severe or concerning.
-
How does COVID-19 spread?COVID-19 spreads when an infected person breathes out droplets and very small particles that contain the virus. These droplets and particles can be breathed in by other people or land on their eyes, noses, or mouth. In some circumstances, they may contaminate surfaces they touch. People who are closer than 6 feet from the infected person are most likely to get infected. COVID-19 is spread in three main ways: Breathing in air when close to an infected person who is exhaling small droplets and particles that contain the virus. Having these small droplets and particles that contain virus land on the eyes, nose, or mouth, especially through splashes and sprays like a cough or sneeze Touching eyes, nose, or mouth with hands that have the virus on them
-
Can I get tested for the variants of the virus that cause COVID-19?Currently, all COVID-19 diagnostic tests can detect all variants, but they will not tell you which variant you have. If you test positive for COVID-19, your sample may be sent to a lab for sequencing to determine which variant is present. For fast turnaround time results; You may schedule (LINK CAN GO HERE--> LEADS TO SCHEDULE PAGE OR FORM!) your RT-PCR (Molecular Test) with us today (INCLUDE LINK!)
-
Can I purchase an Antigen Rapid Test Kit to use at home?Yes, there are several different types of antigen rapid tests you can purchase. Get your kit today! (INCLUDE LINK TO RAPID KIT PAGE!!) Same day shipping! At-home antigen tests are available for the public to purchase to test for COVID-19. Currently, the U.S. Food and Drug Administration (FDA) has authorized antigen rapid test kits for at-home COVID-19 testing under emergency use authorization. The kits are designed to use a self-administered nasal swab. For question regarding test results and what they mean, contact your health care provider. You may also ask for reimbursement through your Health Insurance Plan For a detailed list of FDA antigen tests that are approved or home use, see the FDA website for more information. (INCLUDE LINK TO FDA SITE!)
-
What is a COVID-19 molecular test?Molecular or nucleic acid tests (eg, PCR) check for genetic material (viral RNA) produced by the virus. This helps determine if an individual is currently infected with COVID-19 and can spread it to others. This test is conducted by a nasal swab, or saliva.
-
Can I request COVID-19 test for my child?This program is available to eligible individuals ages 2 and older. Patients between the ages of 2 and 17 must be accompanied to their appointment by a parent or legal guardian. This may vary based on the age of majority in your state.
-
Who should get a COVID-19 Molecular test?You should get tested if: You have symptoms of COVID-19 (such as fever, cough, or shortness of breath) You don’t have symptoms but may have been exposed to COVID-19 You don’t have symptoms and haven’t been recently exposed but live or work in a place where people reside, meet, or gather in close proximity (this can include healthcare settings, homeless shelters, assisted living facilities, group homes, prisons, detention centers, schools, and workplaces) Your employer, public health department, contact investigator, or healthcare provider has identified you as someone who should get tested. If you believe you have symptoms of COVID-19 or that you have been exposed to the virus, you should consult your place of work for specific guidance about whether to stay home or continue working. You schedule your test with us today for fast turnaround time. ( INCLUDE LINK HERE!)
-
When should I get tested?Recommended time to get tested varies based on need. If you’re getting tested for travel or entertainment, check the testing requirements of the venue or carrier, and schedule your appointment within the required window. Please refer to our estimated turnaround times and ensure you leave time to receive your results.
-
How long will it take to get my results?Molecular (eg, PCR) test results are available within 1-3 days. If you require testing for a specific activity, schedule your appointment with as much lead time as your activity allows.
-
How Do I get my COVID-19 test results?You will receive a secure email with your results when they are available. You may also receive the results via a designated cell phone number of your choice.
-
What will my test results tell me?Your test results will tell you whether or not you are currently infected with COVID-19 and/or the flu if you request a COVID-19 and Flu Test. If your results are positive, it is important to isolate immediately and continue to monitor your symptoms. If your results are negative, it means the virus was not detected in the sample you provided.
-
How do I prepare for the test?You do not need to do anything to prepare for the test. You do not need to fast or stop taking any medications before testing. Further instructions will be provided to you at the collection location.
-
Are they any limitations to COVID-19 tests?A molecular test may not detect the virus in early stages of infection. In addition, a molecular test may not detect the virus if there was a problem with your sample, such as when the sample is not collected as directed. A false-negative result can occur in persons who test negative for COVID-19 but have recently been exposed to someone with COVID-19 and who has symptoms consistent with COVID-19.
-
What is considered a close contact?Here are some examples of close contact: Caring for, living with, or visiting someone who has COVID-19. Being near someone (within 6 feet) who has COVID-19 in a confined space. Close contact is defined as: Being within approximately 6 feet (2 meters) of a COVID-19 case for 15 minutes within a 24-hour period, including brief encounters that add up to 15 minutes or more. Having direct contact with infectious secretions of a COVID-19 case (e.g., being coughed on). Having direct physical contact with the person (hugged or kissed them). You shared eating or drinking utensils.
-
How are people monitored after they are exposed to the virus?Public health professionals contact individuals with COVID-19 to ask questions about what people they have recently been in contact with to learn who else might have been exposed to the virus. People who are identified as close contacts of a person with diagnosed COVID-19 will be contacted to determine the status of their health (do they have symptoms of respiratory illness?) and advised to self-quarantine or self-isolate based on their situation and monitor themselves for symptoms. Isolation is for people who have symptoms of respiratory illness or test positive for COVID-19 infection. Quarantine is for people who may have been exposed (close contacts) but do not have any symptoms. The local health department has legal authority to mandate quarantine or isolation for people. They will make this decision based on possible contacts and symptoms, in order to stop the virus from spreading. Because COVID-19 is spreading significantly across the state, public health is unable to contact everyone who may have been exposed to the virus. Individuals should limit their exposure by wearing a mask and staying at least six feet away from others. If an individual becomes sick they should do their best to contact everyone they may have exposed, including notifying their employer or school.
-
Want to learn more about important information about COVID-19 antibody testing?This COVID-19 Antibody Test can detect antibodies from a prior or recent infection, regardless of whether symptoms were present. Positive results may also occur after a COVID-19 vaccination, but the clinical significance is not yet known, nor is it known how good this test is at detecting antibodies in those who have been vaccinated. Alternatively, a nucleocapsid test can only detect antibodies from a prior or recent infection. After a natural infection, current research shows that it may be best to get antibody testing 3 to 4 weeks after symptom onset or known exposure to COVID-19 to increase the opportunity to detect an immune response. After vaccination, it is not yet known how long it takes to develop antibodies. Antibody testing for the purposes of vaccine decision-making is not currently recommended by the CDC. If you test too soon, your body may not have produced enough antibodies to be detected by the test, which can lead to a false negative result. This test can sometimes detect antibodies from other related coronaviruses you may have been exposed to, such as a virus that causes the common cold. This can cause a false positive result. This test should not be used to diagnose an active COVID-19 infection. If an active infection is suspected, molecular or antigen testing is recommended. Learn more about our COVID-19 Active Infection Test. (INCLUDE LINK HERE FOR TEST SCHEDULING AND MORE INFO ABOUT RT-PCR TEST!)
-
Negative Antibody Test ResultsA negative antibody test result means that antibodies were not detected in your blood sample. This can have several possible meanings. It could mean that: You have not been infected with SARS-CoV-2, or You have been infected with SARS-CoV-2, but your antibodies have not reached a sufficient level for the test to be able to detect them, or You have been infected with SARS-CoV-2, but there has not been enough time for antibodies to develop (it can take up to 1 to 3 weeks to develop antibodies after someone is infected, sometimes longer).
-
Positive Antibody Test ResultsA positive antibody test result means that antibodies were detected in your blood sample. This can have a couple of possible meanings. It could mean that: You have been infected with SARS-CoV-2 at some point in the past, or Uncommonly, you may have developed antibodies from an earlier infection with a different virus related to SARS-CoV-2 and the laboratory test cannot distinguish between these other virus antibodies and those antibodies generated in response to SARS-CoV-2.
-
COVID-19 testing statementsThe antibody tests, molecular tests, and antigen tests (together “All tests”) have not been FDA cleared or approved; All tests have been authorized by FDA under EUAs for use by authorized laboratories; The antibody tests have been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens; The molecular tests have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The antigen tests have been authorized only for the detection of proteins from SARS-CoV-2, and not for any other viruses or pathogens; and All tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
-
About the FDA Emergency Use Authorization (EUA) StatusThis test has been authorized by the FDA under an Emergency Use Authorization (EUA). This means that while Quest Diagnostics has validated the test and has the data to believe the test and the collection kit are accurate, this test has not been FDA cleared or approved; This test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the detection of IgG Antibodies against SARS-CoV-2, not for any other viruses or pathogens; and, this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use on in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(B)(1) of the Act, 21 U.S.C. § 360BBB-3(B)(1), unless the authorization is terminated or revoked sooner. Additional studies need to be conducted for this test and others like it to be FDA cleared or approved.
-
Can I get a Certifcate Of Results For Travel?Yes, Certifcate Of Results For Travel will be provided at your request.
About Us
KONE MOLECULAR LABS™ strive on excellence. Our work is performed based on the latest Science, and Technology. Our expert team has a collective brain power of over 80 years; Needless to say, our staff come from a diverse range of backgrounds, experience, and a plethora of educational interests.
Interested in a career with Kone Molecular Labs™? Our Career informational page is coming soon. CONTACT US if you wish to express your desire to work with us.
Our Lab
At KONE MOLECULAR LABS™, we believe our work is essential to community health. By offering close by access, affordable services, and science-based tests, we continue to build a framework that is poised to change as the world does. At KONE MOLECULAR LABS™, we are exploring, and creating new ideas on how to help more people stay safe, and healthy.
Posts • Papers • Publications
Mouse STR
The Consortium for Mouse Cell Line Authentication was formed to validate Short Tandem Repeat (STR) markers for intraspecies identification of mouse cell lines. The STR profiling method is a multiplex polymerase chain reaction (PCR) assay comprised of primers targeting 19 mouse STR markers and two human STR markers (for interspecies contamination screening).
Overall, the interlaboratory study showed that the multiplex PCR method using 18 of the 19 mouse STR markers is capable of discriminating at the intraspecies level between mouse cell lines. Further studies are ongoing to refine the assay including (1) development of an allelic ladder for improving the accuracy of allele calling and (2) integration of stutter filters to identify true stutter.
Rapid Tests &
COVID-19 Variants
DURHAM, NC
Test could measure patient immunity against multiple COVID-19 variants such as Omicron and Delta at once.
Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person’s neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.
This test could potentially tell doctors how protected a patient is from new variants and those currently circulating in a community or, conversely, which monoclonal antibodies to treat a COVID-19 patient. The test is described online in the journal Science Advances.
“In all of our tests, the results largely mimicked what we’ve been seeing in the literature,” said Jake Heggestad, a PhD student working in the Chilkoti lab. “And in this case, not finding anything new is a good sign, because it means our test is working just as well as the methods currently being used.”
SARS-CoV-2 Variants
Evasive Maneuvers
December 3, 2021
Harvard Medical School
New research details how SARS-CoV-2 variants are evolving new ways to evade antibodies, vaccines.
In an effort to predict the future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical School (HMS) has identified several likely mutations that would allow the virus to evade immune defenses, including natural immunity acquired through infection and developed from vaccination as well as antibody-based treatments.
The study, published in Science as an accelerated publication for immediate release, was designed to gauge how SARS-CoV-2 might evolve as it continues to adapt to its human hosts and in doing so to help public health officials and scientists prepare for future mutations.
Indeed, as the research was nearing publication, a new variant of concern, dubbed Omicron, entered the scene and was subsequently found to contain several of the antibody-evading mutations the researchers predicted in the newly published paper. As of December 1, omicron has been identified in 25 countries in Africa, Asia, Australia, Europe, and North and South America, a list that is growing daily.
The Blood-Brain Barrier and SARS-CoV-2
It is unclear whether severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019, can enter the brain. Severe acute respiratory syndrome coronavirus 2 binds to cells via the S1 subunit of its spike protein. We show that intravenously injected radioiodinated S1 (I-S1) readily crossed the blood–brain barrier in male mice, was taken up by brain regions and entered the parenchymal brain space. I-S1 was also taken up by the lung, spleen, kidney and liver. Intranasally administered I-S1 also entered the brain, although at levels roughly ten times lower than after intravenous administration.
APOE genotype and sex did not affect whole-brain I-S1 uptake but had variable effects on uptake by the olfactory bulb, liver, spleen and kidney. I-S1 uptake in the hippocampus and olfactory bulb was reduced by lipopolysaccharide-induced inflammation. Mechanistic studies indicated that I-S1 crosses the blood–brain barrier by adsorptive transcytosis and that murine angiotensin-converting enzyme 2 is involved in brain and lung uptake, but not in kidney, liver or spleen uptake.